Applied Therapeutics Investors Get 1st OK For $15M Deal
Biopharmaceutical company Applied Therapeutics Inc. and its investors have received initial approval of a deal that will end claims related to a 2024 new drug application, including a cash settlement of...To view the full article, register now.
Already a subscriber? Click here to view full article